Advances and challenges in the treatment of myasthenia gravis

Myasthenia gravis (MG) is a chronic autoimmune disease with fluctuating muscle weakness and fatigability. Standard immunomodulatory treatment may fail to achieve sufficient improvement with minimal symptom expression or remission of myasthenic symptoms, despite adequate dosing and duration of treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider-Gold, Christiane, Gilhus, Nils Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721395/
https://www.ncbi.nlm.nih.gov/pubmed/34987614
http://dx.doi.org/10.1177/17562864211065406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721395/
https://www.ncbi.nlm.nih.gov/pubmed/34987614
http://dx.doi.org/10.1177/17562864211065406

Ejemplares similares